Literature DB >> 29304322

Epidemiological patterns of leukaemia in 184 countries: a population-based study.

Adalberto Miranda-Filho1, Marion Piñeros2, Jacques Ferlay2, Isabelle Soerjomataram2, Alain Monnereau3, Freddie Bray2.   

Abstract

BACKGROUND: Leukaemia is a heterogeneous group of haemopoietic cancers that comprises a number of diverse and biologically distinct subgroups. We examine the leukaemia burden worldwide and highlight the distinct incidence patterns in order to elucidate explanatory factors that may support preventive measures and health resource planning. We aimed to estimate the global burden of leukaemia incidence according to the four major subtypes stratified by age and sex.
METHODS: In this population-based study, we assessed leukaemia incidence for the major subtypes using the Cancer Incidence in Five Continents Volume X (CI5-X), which includes data from 290 cancer registries in 68 countries covering the diagnostic period 2003-07, for all ages and both sexes. We then extracted counts and incidence rates in 184 countries for the year 2012 from IARC's GLOBOCAN database of national estimates. We calculated age-specific incidence rates per 100 000 person-years and age-standardised rates (ASRs) using the world standard population by country, sex, age group, and where applicable, by major subtypes. We excluded from all analyses registries for which the total number of leukaemia cases was less than 100 or the proportion of microscopically verified (MV%) cases was less than 80% (2572 cases).
FINDINGS: 717 863 cases between 2003-07 were included in this analysis. More than 350 000 new leukaemia cases were estimated in 2012. We observed substantial variation in incidence between and within world regions. The highest leukaemia incidence rates for both sexes were estimated in Australia and New Zealand (ASR per 100 000 11·3 in males and 7·2 in females), Northern America (10·5 in males and 7·2 in females), and western Europe (9·6 in males and 6·0 in females), and the lowest was in in western Africa (1·4 in males and 1·2 in females). Rates were generally higher in males than females with an overall male to female ratio of 1·4. In children, acute lymphoblastic leukaemia was the main subtype in all studied countries in both sexes, and characterised by a bimodal age-specific pattern. The subtype distribution was more diverse in adults, with a relatively higher proportion of chronic lymphocytic leukaemia in most European and North American countries, whereas rates of acute lymphoblastic leukaemia remained relatively high among adults in selected South American, Caribbean, Asian, and African populations.
INTERPRETATION: Geographical disparities in leukaemia might partly be explained by quality of, and access to, health systems linked to resource levels, although there is probably a role for aetiological factors, including gene-environment interactions. The observed bimodal pattern could be due to different risk factors affecting different ages, and might include a genetic component. FUNDING: European Commission's FP-7 Marie Curie Actions-People-COFUND.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29304322     DOI: 10.1016/S2352-3026(17)30232-6

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN: 2352-3026            Impact factor:   18.959


  44 in total

1.  Frequency of hematologic malignancies in the population of Arica, Chile.

Authors:  Gloria Baeza Pérez; Gloria M Calaf; María Teresa Montalvo Villalba; Katherine Salgado Prieto; Fresia Caba Burgos
Journal:  Oncol Lett       Date:  2019-09-12       Impact factor: 2.967

2.  Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia.

Authors:  Hidefumi Hiramatsu; Souichi Adachi; Katsutsugu Umeda; Itaru Kato; Lamis Eldjerou; Andrea Chassot Agostinho; Kazuto Natsume; Kota Tokushige; Yoko Watanabe; Stephan A Grupp
Journal:  Int J Hematol       Date:  2019-11-11       Impact factor: 2.490

3.  Looking at cancer health disparities without the colored lenses.

Authors:  Mohammad Aslam Khan; Girijesh Kumar Patel; Sanjeev Kumar Srivastava; James Elliot Carter; Jennifer Young Pierce; Rodney Paul Rocconi; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Health Disparities       Date:  2019-08-19

4.  Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Authors:  Shenmiao Yang; Abraham M Varghese; Nitin Sood; Carlos Chiattone; Norah O Akinola; Xiaojun Huang; Robert Peter Gale
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

5.  Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections.

Authors:  Nirojah Subramaniam; Jenny Bottek; Stephanie Thiebes; Kristina Zec; Matthias Kudla; Camille Soun; Elena de Dios Panal; Julia K Lill; Aaron Pfennig; Ralf Herrmann; Kirsten Bruderek; Sven Rahmann; Sven Brandau; Patricia Johansson; Hans Christian Reinhardt; Jan Dürig; Martina Seiffert; Thilo Bracht; Barbara Sitek; Daniel Robert Engel
Journal:  Blood Adv       Date:  2021-03-09

6.  Evaluation of TP53 Codon 72, P21 Codon 31, and MDM2 SNP309 Polymorphisms in Iranian Patients with Acute Lymphocytic Leukemia.

Authors:  Ahmad Lotfi Garavand; Mohammad Mohammadi; Sara Mohammadzadeh
Journal:  Rep Biochem Mol Biol       Date:  2020-04

7.  Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients.

Authors:  Mercy Gatua; Mohsen Navari; Matilda Ong'ondi; Noel Onyango; Serah Kaggia; Emily Rogena; Giuseppe Visani; Nicholas A Abinya; Pier Paolo Piccaluga
Journal:  Front Genet       Date:  2022-06-28       Impact factor: 4.772

8.  The risk of leukemia in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Xiao Luo; Yue He; Wangdong Xu; Mao Liu; Zixia Zhao; Lihui Peng; Chengsong He; Jie Chen
Journal:  Clin Rheumatol       Date:  2020-09-17       Impact factor: 2.980

Review 9.  Epidemiology and Etiology of Leukemia and Lymphoma.

Authors:  Jordan A Baeker Bispo; Paulo S Pinheiro; Erin K Kobetz
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

10.  Poorer Clinical Outcomes for Black Patients with AML: A Wake-Up Call for Better Data and Greater Understanding of Cancer Outcomes in All Ethnic Groups.

Authors:  Paresh Vyas
Journal:  Cancer Discov       Date:  2021-03       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.